Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neurocrine Biosciences (NBIX) Times Interest Earned (2017 - 2024)

Neurocrine Biosciences (NBIX) has disclosed Times Interest Earned for 7 consecutive years, with $90.27 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Times Interest Earned rose 186.95% year-over-year to $90.27, compared with a TTM value of $518.64 through Dec 2024, up 354.76%, and an annual FY2019 reading of $2.26, up 1405.17% over the prior year.
  • Times Interest Earned was $90.27 for Q1 2024 at Neurocrine Biosciences, down from $128.36 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $128.36 in Q3 2023 and bottomed at -$103.82 in Q1 2023.
  • Average Times Interest Earned over 4 years is $16.42, with a median of $7.18 recorded in 2020.
  • The sharpest move saw Times Interest Earned crashed 146.28% in 2020, then skyrocketed 229.37% in 2021.
  • Year by year, Times Interest Earned stood at -$5.21 in 2020, then surged by 229.37% to $6.74 in 2021, then soared by 1803.82% to $128.36 in 2023, then dropped by 29.67% to $90.27 in 2024.
  • Business Quant data shows Times Interest Earned for NBIX at $90.27 in Q1 2024, $128.36 in Q3 2023, and -$103.82 in Q1 2023.